Cellect Biotechnology Ltd. (APOP) News
Filter APOP News Items
APOP News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APOP News Highlights
- For APOP, its 30 day story count is now at 2.
- Over the past 18 days, the trend for APOP's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- RARE, NOV and TEL are the most mentioned tickers in articles about APOP.
Latest APOP News From Around the Web
Below are the latest news stories about Cellect Biotechnology Ltd that investors may wish to consider to help them evaluate APOP as an investment opportunity.
Quoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, AustraliaAddition of Bi-Functional Protein Is Complementary to Lead Asset QRX003 for Netherton SyndromeASHBURN, Va., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has signed an agreement with Queensland University of Technology, Australia (QUT). The agreement is for an exclusive option to a bi-functional protein that has shown promising in-vitro data as |
Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsTel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the previously announced strategic merger with privately-held Quoin Pharmaceuticals, Inc., a specialty pharmaceutical company focused on rare and orphan diseases (the “Merger”) and the sale of the Company’s subsidiary, Cellect Biotherapeutics Ltd., to EnCell |
Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to PopAccording to Fintel, these five short squeeze stocks are among the most likely to see a squeeze attempt moving forward. |
36 Stocks Moving In Tuesday's Mid-Day SessionGainers Digital Brands Group, Inc. (NASDAQ: DBGI) shares climbed 39.3% to $4.1090 after the company issued full-year 2022 revenue guidance of $37.5 million to $42.5 million, representing a 350% increase year-over-year. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) gained 33% to $7.11 after the company announced the OTC consumer launch of Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser on Amazon.com and MucoClyns on Amazon sites in Europe. Gogo Inc. (NASDAQ: GOGO) shares jumped 23. |
Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsTel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 26, 2021, including the sale of the Companys subsidiary, Cellect Biotherapeutics Ltd, to EnCellX Inc. , a privately held company based in San Diego, CA. |
Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike HigherToward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to 4,453.40. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,932,210 cases with around 688,040 deaths. India confirmed a total of at least 33,678,780 cases and 447,190 deaths, while Brazil reported over 21,351,970 COVID-19 cases with 594,440 deaths. In total, there were at least 231,898,110 cases o |
Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares SlideMidway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, gaining 0.02% to 4,456.20. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,932,210 cases with around 688,040 deaths. India confirmed a total of at least 33,678,780 cases and 447,190 deaths, while Brazil reported over 21,351,970 COVID-19 cases with 594,440 deaths. In total, there were at least 231,898,110 cases of CO |
31 Stocks Moving In Monday's Mid-Day SessionGainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission. Cellect Biotechnology Ltd. (NASDAQ: APOP) gained 48.7% to $28.19 after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. ENGlobal Corporation (NASDAQ: ENG) shares gained 28.1% to $2.92. Keros The |
Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In AugustFollowing the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also fell, dropping 0.22% to 4,445.70. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 42,932,210 cases with around 688,040 deaths. India confirmed a total of at least 33,678,780 cases and 447,190 deaths, while Brazil reported over 21,351,970 COVID-19 cases with 594,440 deaths. In total, there were at least 231,898,110 case |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayGood morning, investor! |